ATRA vs TER · rev $128.9M vs P/E 76, rev $2.82B
Atara Biotherapeutics Inc (ATRA) versus Teradyne Inc (TER) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Teradyne Inc (TER) is a semiconductor equipment & materials company listed on NASDAQ.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported TER revenue for 2024-12-31 was $2.82B. Net income was $542.4M. Revenue was up 5.4% from 2023-12-31 to 2024-12-31. TER currently screens at market cap $63.96B and trailing P/E 75.7.
ATRA currently screens at market cap $87.1M. TER currently screens at market cap $63.96B and trailing P/E 75.7.
Not investment advice. Open the ATRA and TER stock pages for the full models.
Not investment advice.